For individuals battling Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a debilitating condition, the arrival of this treatment and Attruby represents a true advancement . These groundbreaking therapies preserve the transthyretin protein, preventing its damaging build-up and reducing the burden of the condition . Individuals are now reporting i… Read More